학술논문
Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial
Document Type
Article
Author
Spinazzi, E.F.; Argenziano, M.G.; Upadhyayula, P.S.; Banu, M.A.; Neira, J.A.; Higgins, D.M.O.; Mahajan, A.; Humala, N.; Gill, B.J.A.; Boyett, D.M.; Marie, T.; Furnari, J.L.; Sudhakar, T.D.; Good, L.; Petridis, P.; Bruce, J.N.; Pereira, B.; Al-Dalahmah, O.; Canoll, P.; Zhao, W.; Sims, P.A.; Zacharoulis, S.; Behl, M.; Jambawalikar, S.; Mintz, A.; Lignelli, A.; Grinband, J.; Wu, P.B.; Save, A.V.; Stopka, S.A.; Agar, N.Y.R.; Regan, M.S.; Catania, V.; Welch, M.R.; Lassman, A.B.; Iwamoto, F.M.; D'Amico, R.S.
Source
In: The Lancet Oncology . (The Lancet Oncology, November 2022, 23(11):1409-1418)
Subject
Language
English
ISSN
14745488
14702045
14702045